Selected article for: "immune system and viral surface"

Author: Bachmann, Martin F.; Mohsen, Mona O.; Zha, Lisha; Vogel, Monique; Speiser, Daniel E.
Title: SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
  • Cord-id: r2x8lp4w
  • Document date: 2021_1_4
  • ID: r2x8lp4w
    Snippet: Neutralizing antibody responses of SARS-CoV-2-infected patients may be low and of short duration. We propose here that coronaviruses employ a structural strategy to avoid strong and enduring antibody responses. Other viruses induce optimal and long-lived neutralizing antibody responses, thanks to 20 or more repetitive, rigid antigenic epitopes, spaced by 5–10 nm, present on the viral surface. Such arrays of repetitive and highly organized structures are recognized by the immune system as patho
    Document: Neutralizing antibody responses of SARS-CoV-2-infected patients may be low and of short duration. We propose here that coronaviruses employ a structural strategy to avoid strong and enduring antibody responses. Other viruses induce optimal and long-lived neutralizing antibody responses, thanks to 20 or more repetitive, rigid antigenic epitopes, spaced by 5–10 nm, present on the viral surface. Such arrays of repetitive and highly organized structures are recognized by the immune system as pathogen-associated structural patterns (PASPs), which are characteristic for pathogen surfaces. In contrast, coronaviruses are large particles with long spikes (S protein) embedded in a fluid membrane. Therefore, the neutralizing epitopes (which are on the S protein) are loosely “floating” and widely spaced by an average of about 25 nm. Consequently, recruitment of complement is poor and stimulation of B cells remains suboptimal, offering an explanation for the inefficient and short-lived neutralizing antibody responses.

    Search related documents:
    Co phrase search for related documents
    • acute disease and live virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • acute disease and long genome: 1
    • acute disease and long term follow: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • acute disease and low amount: 1, 2
    • acute disease and low number: 1, 2, 3, 4, 5, 6, 7, 8
    • acute disease cause and live virus: 1
    • acute disease cause and long term follow: 1